VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 44 filers reported holding VINCERX PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103,069 | -22.3% | 102,049 | 0.0% | 0.03% | -5.9% |
| Q2 2023 | $132,664 | +25.0% | 102,049 | 0.0% | 0.03% | -34.6% |
| Q1 2023 | $106,131 | +2.0% | 102,049 | 0.0% | 0.05% | +36.8% |
| Q4 2022 | $104,090 | -26.2% | 102,049 | 0.0% | 0.04% | -15.6% |
| Q3 2022 | $141,000 | +4.4% | 102,049 | 0.0% | 0.04% | -11.8% |
| Q2 2022 | $135,000 | -66.9% | 102,049 | 0.0% | 0.05% | -62.2% |
| Q1 2022 | $408,000 | -60.8% | 102,049 | 0.0% | 0.14% | -57.0% |
| Q4 2021 | $1,040,000 | -37.0% | 102,049 | 0.0% | 0.31% | -40.3% |
| Q3 2021 | $1,650,000 | -9.8% | 102,049 | -27.6% | 0.53% | +15.6% |
| Q2 2021 | $1,830,000 | -9.7% | 140,913 | +34.2% | 0.46% | +10.7% |
| Q1 2021 | $2,027,000 | -35.3% | 105,000 | -29.9% | 0.41% | -36.0% |
| Q4 2020 | $3,134,000 | – | 149,892 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,618,199 | $31,231,000 | 10.26% |
| Affinity Asset Advisors, LLC | 543,010 | $10,480,000 | 3.56% |
| ACUTA CAPITAL PARTNERS, LLC | 394,000 | $7,604,000 | 2.74% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $9,650,000 | 2.72% |
| Logos Global Management LP | 480,000 | $9,264,000 | 0.90% |
| Sio Capital Management, LLC | 105,000 | $2,027,000 | 0.41% |
| SABBY MANAGEMENT, LLC | 82,948 | $1,601,000 | 0.31% |
| Monashee Investment Management LLC | 99,999 | $1,930,000 | 0.30% |
| Ikarian Capital, LLC | 438,684 | $8,467,000 | 0.28% |
| RTW INVESTMENTS, LP | 500,000 | $9,650,000 | 0.15% |